Both in Medical Labs
CareDx vs Veracyte
Over the past year CDNA returned +330.8% and VCYT returned +37.1%; their daily moves had a correlation of 0.30.
CDNA +330.8% VCYT +37.1%Growth of $1, one year, split-adjusted
| Metric | CDNA | VCYT |
|---|---|---|
| Price | $64.02 | $46.08 |
| Market cap | $3.31B | $3.70B |
| Today | −0.90% | +1.88% |
| 1 month | +28.6% | +6.3% |
| 6 months | +289.7% | +51.4% |
| Year to date | +239.8% | +9.5% |
| 1 year | +328.8% | +37.8% |
| Revenue growth (YoY) | +52.2% | +15.5% |
| Gross margin | 73.5% | 72.2% |
| Net margin | 83.8% | 17.0% |
| P/E (TTM) | 29.8× | 32.4× |
| Price / sales | 7.2× | 6.6× |
| Net cash | $373.6M | $485.2M |
| Dividend yield | — | — |
| Volatility (60d) | 82.6% | 74.2% |
| Short % of float | 12.5% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).